Partnership with an African American sorority to enhance participation in cancer genetics research

Community Genetics

Volumn 11, Issue 4, 2008, Pages 201-207

  Olsen, Sharon J ^a   Malvern, Kathryn T ^b   May, Betty J ^a   Jenkins, Issie L ^b   Griffin, Constance A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b National Educational Foundation   (United States)

Author keywords

African American; Cancer; Cancer Genetics Network; Genetics; Recruitment; Research

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RESEARCH; DESCRIPTIVE RESEARCH; FAMILIAL CANCER; FEMALE; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; ORGANIZATION; PILOT STUDY; POSTAL MAIL; PRIORITY JOURNAL; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; FEMALE; GENETIC RESEARCH; HUMANS; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASMS; PATIENT PARTICIPATION; PEER GROUP; QUESTIONNAIRES; REGISTRIES; STUDENTS;

EID: 42349091321     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000116880     Document Type: Article

References (19)

1. National Institutes of Health: NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Fed Regist 1994;59:14508-14513.
2. Moorman PG, Newman B, Millikan RC, Tse CK, Sandler DP: Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol 1999;9:188-195.
3. Richardson MA, Post-White J, Singletary SE, Justice B: Recruitment for complementary/alternative medicine trials: who participates after breast cancer. Ann Behav Med 1998;20:190-198.
4. Lerman C, Hughes C, Benkendorf JL, Biesecker B, Kerner J, Willison J, Eads N, Hadley D, Lynch J: Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 1999;8:361-367.
5. Moinpour CM, Atkinson JO, Thomas SM, Underwood SM, Harvey C, Parzuchowski J, Lovato LC, Ryan AM, Hill MS, Deantoni E, Gritz ER, Thompson IM Jr, Coltman CA Jr: Minority recruitment in the prostate cancer prevention trial. Ann Epidemiol 2000;10:S85-S91.
6. Gifford AL, Cunningham WE, Heslin KC, Andersen RM, Nakazono T, Lieu DK, Shapiro MF, Bozzette SA: HIV Cost and Services Utilization Study Consortium: participation in research and access to experimental treatments by HIV infected patients. N Engl J Med 2002;346:1373-1382.
7. Adams-Campbell LL, Ahaghotu C, Gaskins M, Dawkins FW, Smoot D, Polk OD, Gooding R, DeWitty RL: Enrollment of AAs into clinical treatment trials: study design barriers. J Clin Oncol 2004;22:730-734.
8. Levkoff S, Sanchez H: Lessons learned about minority recruitment and retention from Centers on Minority Aging and Health Promotion. Gerontologist 2003;43:18-26.
9. Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, Rimer B, Schildkraut J, Strong L, Weber B, Winn D, Hiatt R, Nayfield S: The Cancer Genetics Network: Recruitment results and pilot studies. Community Genet 2003;6:171-177.
10. Nagy R, Sweet K, Eng C: Highly penetrant hereditary cancer syndromes. Oncogene 2004;23:6445-6470.
11. Whelton PK, Lee JY, Kusek JW, Charleston J, DeBruge J, Douglas M, Faulkner M, Greene PG, Jones CA, Kiefer S, Kirk KA, Levell B, Norris K, Powers SN, Retta TM, Smith DE, Ward H: Recruitment experience in the African American study of kidney disease and hypertension (AASK) pilot study. Control Clin Trials 1996;17:17s-33s.
12. Royal C, Baffoe-Bonnie A, Kittles R, Powell I, Bennett J, Hoke G, Pettaway C, Weinrich S, Vijayakumar S, Ahaghotu C, Mason T, Johnson E, Obeikwe M, Simpson C, Mejia R, Boykin W, Roberson P, Frost J, Faison-Smith L, Meegan C, Foster N, Furbert-Harris P, Carpten J, Bailey-Wilson J, Trent J, Berg K, Dunston G, Collins F: Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) Study. Ann Epidemiol 2000;10:S68-S77.
13. Moorman PG, Skinner CS, Evans JP, Newman B, Sorenson JR, Calingaert B, Susswein L, Crankshaw TS, Hoyo C, Schildkraut JM: Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev 2004;13:1349-1354.
14. Hughes C, Gomez-Caminero A, Benkendorf J, Kerner J, Isaacs C, Barter J, Lerman C: Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Counsel 1997;32:51-62.
15. Lerman D, Audrain J, Croyle R: DNA-testing for heritable breast cancer risks: lessons from traditional genetic counseling. Ann Behav Med 1994:16:327-333.
16. Halbert CH, Kessler L, Collier A, Paul Wileyto E, Breswter K, Weathers B: Psychological functioning in African American women at an increased risk of hereditary breast and ovarian cancer. Clin Genet 2005;68:222-227.
17. Donovan KA, Tucker DC: Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample. J Behav Med 2000;23:15-36.
18. Peters N, Rose A, Armstrong K: The association between race and attitudes about predictive genetic testing. Cancer Epidemiol Biomarkers Prev 2004;13:361-365.
19. Wideroff L, Vadaparampil ST, Breen N, Croyle RT, Freedman AN: Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genet 2003;6:147-156.